Cargando…

Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud

Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5(+) DM) is an infrequent autoimmune disease, which mainly distributes in Asians and females. MDA5(+) DM usually presents various skin lesions and positive anti-MDA5 antibody (a myositis-specific autoantibody for i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jinming, Yan, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584642/ https://www.ncbi.nlm.nih.gov/pubmed/36275649 http://dx.doi.org/10.3389/fimmu.2022.1009546

Ejemplares similares

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?
por: Utsumi, Takahiro, et al.
Publicado: (2023)

Nipping Adipocyte Inflammation in the Bud
por: Griffin, Michael J.
Publicado: (2021)

Drug-induced resistance: nipping it in the ‘budding’
por: Goldman, Aaron
Publicado: (2018)

Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease
por: Gui, Xianhua, et al.
Publicado: (2022)

Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome
por: Ding, Yukang, et al.
Publicado: (2022)

Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis
por: Chen, Cuihong, et al.
Publicado: (2021)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis
por: Li, Meiqi, et al.
Publicado: (2023)

Anti–melanoma differentiation–associated gene 5 dermatomyositis complicated by myopericarditis
por: Milani-Nejad, Nima, et al.
Publicado: (2019)

The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients
por: Chen, Xixia, et al.
Publicado: (2022)

Nipping Diseases in the Bud? Ethical and Social Considerations of the Concept of ‘Disease Interception’
por: Narchi, Jonas, et al.
Publicado: (2021)

Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review
por: He, Chenjia, et al.
Publicado: (2022)

Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
por: Qian, Jinjing, et al.
Publicado: (2023)

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
por: Nombel, Anaïs, et al.
Publicado: (2021)

Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Isono, Taisuke, et al.
Publicado: (2021)

Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System
por: Hu, Huifang, et al.
Publicado: (2022)

ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis
por: Matsuo, Takashi, et al.
Publicado: (2022)

Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
por: Zhang, Suo, et al.
Publicado: (2022)

Nipped in the Bud: COVID-19 Reveals the Malleability of STEM Student Self-Efficacy
por: Camfield, Eileen Kogl, et al.
Publicado: (2021)

PI3Kα targeting, nipping pancreatic cancer evolution in the bud
por: Raja Arul, Glancis Luzeena, et al.
Publicado: (2021)

Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia
por: Kurushima, Shota, et al.
Publicado: (2017)

AC-X: Characteristic Antinuclear Antibody Patterns of Two Anti-Mi-2 Autoantibody-Positive Dermatomyositis Patients—A Case Report
por: Wu, Ziyan, et al.
Publicado: (2022)

Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report
por: Watanabe, Tsuyoshi, et al.
Publicado: (2020)

Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
por: Xue, Yuan, et al.
Publicado: (2023)

Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes
por: Halim, Talha Abdul, et al.
Publicado: (2013)

Anti-PL-7 antibody-positive dermatomyositis with progressive interstitial pneumonia complicated with tracheal ulcer
por: Sato, Shintaro, et al.
Publicado: (2021)

Nip and Snarler
Publicado: (1867)

An unusual anti–melanoma differentiation–associated protein 5 amyopathic dermatomyositis
por: Barailler, Héloïse, et al.
Publicado: (2019)

Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis
por: Yamamoto, Shotaro, et al.
Publicado: (2021)

Anti-melanoma differentiation-associated gene 5 and anti-Ro52 antibody-dual positive dermatomyositis accompanied by rapidly lung disease: Three case reports
por: Ye, Wen-Zheng, et al.
Publicado: (2023)

Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan
por: Muro, Yoshinao, et al.
Publicado: (2011)

Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome
por: Zuo, Yu, et al.
Publicado: (2022)

Presence and Implications of Anti‐Angiotensin Converting Enzyme‐2 Immunoglobulin M Antibodies in Anti‐Melanoma‐Differentiation‐Associated 5 Dermatomyositis
por: Mecoli, Christopher A., et al.
Publicado: (2022)

The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease
por: Wakura, Reiko, et al.
Publicado: (2020)

Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis
por: Weng, Chenghua, et al.
Publicado: (2022)

Dermatomyositis Complicated by Digital Ischemia and Lung Adenocarcinoma in a Patient with Positive Anti-signal Recognition Particle Antibodies
por: Nawata, Takashi, et al.
Publicado: (2017)

The NIPS '17 competition
por: Escalera, Sergio, et al.
Publicado: (2018)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
por: Lv, Xia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_83mpe8h6las09snm8m4d2cq2mp